M Tiemann
Overview
Explore the profile of M Tiemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kotter I, et al.
Z Rheumatol
. 2024 Aug;
83(Suppl 3):289-298.
PMID: 39174716
No abstract available.
2.
Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kotter I, et al.
Z Rheumatol
. 2023 Aug;
83(4):316-326.
PMID: 37624374
The term Castleman's disease encompasses a group of rare lymphoproliferative diseases that show histopathological similarities in lymph node biopsy. Diagnostic criteria and a specific ICD-10 code have been available for...
3.
Ramdani H, Falk M, Heukamp L, Schatz S, Tiemann M, Wesseler C, et al.
Pathol Res Pract
. 2021 Oct;
227:153651.
PMID: 34673351
Methods: Patients with advanced NSCLC treated with ICI single agent were divided into responders and non-responders according to RECIST v1.1 and duration of response (DOR) criteria. Immunohistochemistry was performed on...
4.
Atiakshin D, Shishkina V, Gerasimova O, Meshkova V, Samodurova N, Samoilenko T, et al.
Acta Histochem
. 2021 Apr;
123(4):151711.
PMID: 33838578
To increase the efficiency of interpretation of mast cell's contribution to the state of a specific tissue microenvironment, it is necessary to detail the molecular composition of their secretome and...
5.
Bruckl W, Ficker J, Tiemann M, Schumann C, Reinmuth N, Heigener D, et al.
Pneumologie
. 2018 Aug;
72(9):617-623.
PMID: 30071539
Performing rebiopsies for primary lung cancer and/or their metastases is becoming more and more prominent in daily practice, as the therapeutical spectrum increases and some newer strategies are dependent on...
6.
Scheel A, Dietel M, Heukamp L, Johrens K, Kirchner T, Reu S, et al.
Pathologe
. 2016 Aug;
37(6):557-567.
PMID: 27510417
Background: Antibodies against PD-1 and PD-L1 can cause strong and durable anti-tumor immune responses in non-small cell lung cancer (NSCLC). Immunohistochemistry for PD-L1 (PD-L1 IHC) was tested as a predictive...
7.
Brehm W, Bos K, Graf C, Hartmann H, Pahmeier I, Pfeifer K, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2013 Aug;
56(10):1385-9.
PMID: 23978982
Physical activities are particularly health effective when they are structured and systematically organized, for example, with respect to a dose-response relationship or to psychosocial aspects. Which insights can be gained...
8.
Cordes C, Tiemann M, Tiemann K, Knappe D, Hoffmann M, Gottschlich S
B-ENT
. 2011 May;
7(1):43-6.
PMID: 21563556
Problems/objectives: Epstein-Barr virus (EBV) is commonly associated with nasopharyngeal carcinoma and Burkitt's lymphoma, but association with hypopharyngeal and laryngeal tumours is rare. To the best of our knowledge, this is...
9.
Uthoff D, Schmidt S, Matthies C, Tiemann M, Wagner W
Aktuelle Urol
. 2009 Jan;
40(2):113-5.
PMID: 19177323
Introduction: First description of a prostate adenocarcinoma coinciding with the rare MALT lymphoma of the prostate. Case Report: 68-year-old patient with a pT2c, pN0, M0, Gleason 3 + 3 prostate...
10.
Siegel S, Friedrichs B, Budde A, Barsoum A, Coggin Jr J, Tiemann M, et al.
Leukemia
. 2008 May;
22(11):2115-8.
PMID: 18449203
No abstract available.